You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation

Authors

  1. Correspondence to Erik Lubberts, Departments of Rheumatology and Immunology, Erasmus MC, University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands; e.lubberts{at}erasmusmc.nl
View Full Text

Citation

van Hamburg JP, Asmawidjaja PS, Davelaar N, et al
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
Annals of the Rheumatic Diseases 2012;71:606-612.

Publication history

  • Received October 6, 2011
  • Accepted October 31, 2011
  • First published January 4, 2012.
Online issue publication 
February 28, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions